To see the relation of excretion of certain molecules in urine with a decline in renal function in chronic kidney disease.
Not Applicable
Not yet recruiting
- Conditions
- Health Condition 1: N118- Other chronic tubulo-interstitialnephritis
- Registration Number
- CTRI/2023/03/051048
- Lead Sponsor
- Dr RMLIMS
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Not Yet Recruiting
- Sex
- Not specified
- Target Recruitment
- 0
Inclusion Criteria
patients of CKD with GFR between 20ml/min to 60ml/min
Exclusion Criteria
pregnancy, cirrhosis, severe heart failure, hospitalization in the last 3 months, proteinuria >1gm
Study & Design
- Study Type
- Observational
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method To assess the relationship of longitudinal changes in eGFR with the baseline secretion score of endogenous secretory moleculesTimepoint: Every 3 months till completion of the study
- Secondary Outcome Measures
Name Time Method Chronic kidney disease (CKD) progression (â?¥50% eGFR decline or incident kidney failure requiring dialysis or kidney transplantation), a cardiovascular disease (CVD) composite (myocardial infarction, acute coronary syndrome, stroke, acute decompensated heart failure or death from cardiovascular causes)Timepoint: Every 3 months till completion of study